08/14/2025
4:26 PM | PALVELLA THERAPEUTICS, INC. (Subject)
Palvella Therapeutics (Subject)
Samsara BioCapital, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
08/14/2025
7:00 AM | PALVELLA THERAPEUTICS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2025
6:30 AM | PALVELLA THERAPEUTICS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2025
6:59 PM | Davis Todd C (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
6:59 PM | HERON ELAINE J (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
6:59 PM | JENKINS GEORGE M (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
6:59 PM | KIRITSY CHRISTOPHER P (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
7:00 PM | PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
Wessel Tadd S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2025
8:15 PM | Kline Ashley Hartmann (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2025
8:08 PM | Kline Ashley Hartmann (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/15/2025
8:39 AM | Frazier Life Sciences Public Fund, L.P. (Filed by)
PALVELLA THERAPEUTICS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
Get the Latest News and Ratings for PVLA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Palvella Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
05/15/2025
6:31 AM | PALVELLA THERAPEUTICS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2025
6:45 AM | PALVELLA THERAPEUTICS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/10/2025
6:06 PM | JENKINS GEORGE M (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/31/2025
6:51 AM | PALVELLA THERAPEUTICS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/31/2025
6:32 AM | PALVELLA THERAPEUTICS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2025
7:00 AM | PALVELLA THERAPEUTICS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/10/2025
5:25 PM | Kaupinen Wes (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4/A | |
02/10/2025
4:40 PM | Goin Kathleen (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4/A | |
02/10/2025
5:00 PM | Martini Jeffrey S (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4/A | |
02/10/2025
4:21 PM | Korenberg Matthew E (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4/A | |
02/07/2025
3:29 PM | PALVELLA THERAPEUTICS, INC. (Reporting)
Palvella Therapeutics (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
3:29 PM | PALVELLA THERAPEUTICS, INC. (Reporting)
Palvella Therapeutics (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
3:30 PM | PALVELLA THERAPEUTICS, INC. (Reporting)
Palvella Therapeutics (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
3:30 PM | PALVELLA THERAPEUTICS, INC. (Reporting)
Palvella Therapeutics (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2025
11:15 PM | PALVELLA THERAPEUTICS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form EFFECT | |
01/14/2025
5:22 AM | PALVELLA THERAPEUTICS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form S-1/A | |
01/13/2025
6:00 AM | PALVELLA THERAPEUTICS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
2:04 PM | Frazier Life Sciences Public Fund, L.P. (Filed by)
PALVELLA THERAPEUTICS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form SCHEDULE 13G | |
12/31/2024
5:04 AM | PALVELLA THERAPEUTICS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
12/20/2024
4:32 PM | Kaupinen Wes (Filed by)
PALVELLA THERAPEUTICS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form SCHEDULE 13D | |
12/20/2024
3:56 PM | PALVELLA THERAPEUTICS, INC. (Subject)
Palvella Therapeutics (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SCHEDULE 13G | |
12/20/2024
3:59 PM | PALVELLA THERAPEUTICS, INC. (Subject)
Palvella Therapeutics (Subject)
Samsara BioCapital, L.P. (Filed by)
| Form SCHEDULE 13G | |
12/19/2024
9:23 AM | JENKINS GEORGE M (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
7:45 PM | PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
Wessel Tadd S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
7:46 PM | HERON ELAINE J (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
7:40 PM | KIRITSY CHRISTOPHER P (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
7:41 PM | Kaupinen Wes (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
7:42 PM | JENKINS GEORGE M (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
7:43 PM | Korenberg Matthew E (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
7:43 PM | Goin Kathleen (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
A Major Economic Change Is Happening Now (Ad) Louis Navellier is one of Wall Street’s most respected money managers — overseeing more than $7 billion and earning a reputation for fact-based analysis, not sensationalism. That’s why his latest economic warning is turning so many heads.
In his new report, Louis reveals how recent policies are accelerating a massive economic shift. While headlines point to strong numbers, everyday Americans feel the squeeze as prices climb and industries are reshaped. According to Louis, this transformation could determine who falls behind — and who builds lasting wealth. Read Louis Navellier’s urgent report here |
12/17/2024
7:44 PM | Martini Jeffrey S (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
7:44 PM | Davis Todd C (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
4:42 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
PALVELLA THERAPEUTICS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form SC 13G/A | |
12/17/2024
4:44 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
LAMPERT MARK N (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
3:22 PM | Dellora Investments LP (Filed by)
PALVELLA THERAPEUTICS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
12/16/2024
6:40 PM | HERON ELAINE J (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/16/2024
6:41 PM | Davis Todd C (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/16/2024
6:41 PM | JENKINS GEORGE M (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/16/2024
6:42 PM | Martini Jeffrey S (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/16/2024
6:43 PM | Goin Kathleen (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/16/2024
6:43 PM | Kaupinen Wes (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/16/2024
6:44 PM | PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
Wessel Tadd S. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/16/2024
6:44 PM | Korenberg Matthew E (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/16/2024
3:18 PM | Dellora Investments LP (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
8:53 PM | PALVELLA THERAPEUTICS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2024
3:15 PM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2024
3:15 PM | PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form 425 | |
12/12/2024
3:16 PM | GERAGHTY JAMES A (Reporting)
PIERIS PHARMACEUTICALS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
6:32 AM | KIRITSY CHRISTOPHER P (Reporting)
PIERIS PHARMACEUTICALS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
1:21 PM | Dellora Investments LP (Filed by)
PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
12/03/2024
7:30 AM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/03/2024
7:30 AM | PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form 425 | |
11/18/2024
3:16 PM | Dellora Investments LP (Reporting)
PIERIS PHARMACEUTICALS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/14/2024
8:07 AM | Lynx1 Capital Management LP (Filed by)
PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form SC 13G/A | |
11/13/2024
3:02 PM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
8:01 AM | PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form 425 | |
11/07/2024
7:47 AM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form S-4/A | |
11/06/2024
4:00 PM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form ARS | |
11/06/2024
4:01 PM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form DEF 14A | |
11/05/2024
4:01 PM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form S-4/A | |
10/29/2024
7:45 AM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form S-4/A | |
10/28/2024
4:18 PM | GERAGHTY JAMES A (Reporting)
PIERIS PHARMACEUTICALS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2024
7:00 AM | PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form 425 | |
10/15/2024
7:30 AM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form S-4/A | |
10/15/2024
7:00 AM | PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form 425 | |
10/03/2024
7:00 AM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
7:00 AM | PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form 425 | |
09/23/2024
5:15 AM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form S-4/A | |
MarketBeat All Access